Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

2Total

Not Applicable (2)

Trial Status

Completed4

Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT04382131Not ApplicableTerminated

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

NCT05794412Completed

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

NCT03463694Not ApplicableCompleted

Edinburgh and Lothian Virus Intervention Study in Kids

NCT02733796Completed

Persistence of Zika Virus in Semen After Acute Infection

NCT02638493Completed

The Compartmental Biology of HIV in the Male Genital Tract

Showing all 5 trials

Virus Shedding